Singh Randolph R, Lai Adelene, Krier Jessy, Kondić Todor, Diderich Philippe, Schymanski Emma L
Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 6 avenue du Swing, 4367 Belvaux, Luxembourg.
IFREMER (Institut Français de Recherche pour l'Exploitation de la Mer), Laboratoire Biogéochimie des Contaminants Organiques, Rue de l'Ile d'Yeu, BP 21105, Nantes 44311 Cedex 3, France.
ACS Environ Au. 2021 Jul 29;1(1):58-70. doi: 10.1021/acsenvironau.1c00008. eCollection 2021 Nov 17.
Pharmaceuticals and their transformation products (TPs) are continuously released into the aquatic environment via anthropogenic activity. To expand knowledge on the presence of pharmaceuticals and their known TPs in Luxembourgish rivers, 92 samples collected during routine monitoring events between 2019 and 2020 were investigated using nontarget analysis. Water samples were concentrated using solid-phase extraction and then analyzed using liquid chromatography coupled to a high-resolution mass spectrometer. Suspect screening was performed using several open source computational tools and resources including Shinyscreen (https://git-r3lab.uni.lu/eci/shinyscreen/), MetFrag (https://msbi.ipb-halle.de/MetFrag/), PubChemLite (https://zenodo.org/record/4432124), and MassBank (https://massbank.eu/MassBank/). A total of 94 pharmaceuticals, 88 confirmed at a level 1 confidence (86 of which could be quantified, two compounds too low to be quantified) and six identified at level 2a, were found to be present in Luxembourg rivers. Pharmaceutical TPs (12) were also found at a level 2a confidence. The pharmaceuticals were present at median concentrations up to 214 ng/L, with caffeine having a median concentration of 1424 ng/L. Antihypertensive drugs (15), psychoactive drugs (15), and antimicrobials (eight) were the most detected groups of pharmaceuticals. A spatiotemporal analysis of the data revealed areas with higher concentrations of the pharmaceuticals, as well as differences in pharmaceutical concentrations between 2019 and 2020. The results of this work will help guide activities for improving water management in the country and set baseline data for continuous monitoring and screening efforts, as well as for further open data and software developments.
药物及其转化产物(TPs)通过人为活动不断释放到水生环境中。为了扩展对卢森堡河流中药物及其已知TPs存在情况的了解,使用非靶向分析方法对2019年至2020年期间常规监测活动中采集的92个样本进行了调查。水样通过固相萃取进行浓缩,然后使用液相色谱与高分辨率质谱仪联用进行分析。使用包括Shinyscreen(https://git-r3lab.uni.lu/eci/shinyscreen/)、MetFrag(https://msbi.ipb-halle.de/MetFrag/)、PubChemLite(https://zenodo.org/record/4432124)和MassBank(https://massbank.eu/MassBank/)在内的几种开源计算工具和资源进行可疑物筛查。在卢森堡河流中总共发现了94种药物,其中88种在置信水平1得到确认(其中86种可以定量,两种化合物浓度过低无法定量),6种在2a级得到鉴定。还发现了12种药物TPs,置信水平为2a。这些药物的中位浓度高达214 ng/L,咖啡因的中位浓度为1424 ng/L。抗高血压药物(15种)、精神活性药物(15种)和抗菌药物(8种)是检测到的最多的药物类别。对数据的时空分析揭示了药物浓度较高的区域,以及2019年和2020年之间药物浓度的差异。这项工作的结果将有助于指导该国改善水资源管理的活动,并为持续监测和筛查工作以及进一步的开放数据和软件开发设定基线数据。